Separation of the available RME set in patients with low, intermediate or high risk tumors revealed more numerous tumor infiltrating CD3 and CD8 positive cells in patients with low risk tumors (Supplemental Fig. S5) compared to intermediate and high risk tumors. Here, CD8A is linked to neoplasm.